CCL21 and lung cancer: From a clinical perspective, a project aimed at exploiting vaults packaged with CCL21-INT for lung cancer therapy is currently in phase I [213], whereas MVP immunohistochemistry makes is possible to reliably identify potential markers of malignancy in uterine smooth muscle tumors [222].